Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunol ; 184(12): 7040-6, 2010 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-20488797

RESUMO

The P2X7R is highly expressed on the macrophage cell surface, and activation of infected cells by extracellular ATP has been shown to kill intracellular bacteria and parasites. Furthermore, single nucleotide polymorphisms that decrease receptor function reduce the ability of human macrophages to kill Mycobacterium tuberculosis and are associated with extrapulmonary tuberculosis. In this study, we show that macrophages from people with the 1513C (rs3751143, NM_002562.4:c.1487A>C) loss-of-function P2X7R single nucleotide polymorphism are less effective in killing intracellular Toxoplasma gondii after exposure to ATP compared with macrophages from people with the 1513A wild-type allele. Supporting a P2X7R-specific effect on T. gondii, macrophages from P2X7R knockout mice (P2X7R-/-) are unable to kill T. gondii as effectively as macrophages from wild-type mice. We show that P2X7R-mediated T. gondii killing occurs in parallel with host cell apoptosis and is independent of NO production.


Assuntos
Macrófagos/imunologia , Receptores Purinérgicos P2/genética , Toxoplasmose/genética , Animais , Apoptose/imunologia , Separação Celular , Citometria de Fluxo , Humanos , Macrófagos/metabolismo , Camundongos , Camundongos Knockout , Óxido Nítrico/biossíntese , Óxido Nítrico/imunologia , Polimorfismo de Nucleotídeo Único , Receptores Purinérgicos P2/imunologia , Receptores Purinérgicos P2/metabolismo , Receptores Purinérgicos P2X7 , Toxoplasma , Toxoplasmose/imunologia , Toxoplasmose/metabolismo , Toxoplasmose Animal/genética , Toxoplasmose Animal/metabolismo
2.
PLoS One ; 3(6): e2285, 2008 Jun 04.
Artigo em Inglês | MEDLINE | ID: mdl-18523590

RESUMO

BACKGROUND: Primary Toxoplasma gondii infection during pregnancy can be transmitted to the fetus. At birth, infected infants may have intracranial calcification, hydrocephalus, and retinochoroiditis, and new ocular lesions can occur at any age after birth. Not all children who acquire infection in utero develop these clinical signs of disease. Whilst severity of disease is influenced by trimester in which infection is acquired by the mother, other factors including genetic predisposition may contribute. METHODS AND FINDINGS: In 457 mother-child pairs from Europe, and 149 child/parent trios from North America, we show that ocular and brain disease in congenital toxoplasmosis associate with polymorphisms in ABCA4 encoding ATP-binding cassette transporter, subfamily A, member 4. Polymorphisms at COL2A1 encoding type II collagen associate only with ocular disease. Both loci showed unusual inheritance patterns for the disease allele when comparing outcomes in heterozygous affected children with outcomes in affected children of heterozygous mothers. Modeling suggested either an effect of mother's genotype, or parent-of-origin effects. Experimental studies showed that both ABCA4 and COL2A1 show isoform-specific epigenetic modifications consistent with imprinting. CONCLUSIONS: These associations between clinical outcomes of congenital toxoplasmosis and polymorphisms at ABCA4 and COL2A1 provide novel insight into the molecular pathways that can be affected by congenital infection with this parasite.


Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Colágeno Tipo II/genética , Epigênese Genética , Toxoplasmose Congênita/genética , Encéfalo/patologia , Estudos de Coortes , Olho/patologia , Impressão Genômica , Genótipo , Humanos , Desequilíbrio de Ligação , Toxoplasmose Congênita/patologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...